Zelalem Eshete

Array ( [id] => 5023812 [patent_doc_number] => 20070149778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'BECKMANN REARRANGEMENT USING MOLECULAR SIEVE SSZ-74' [patent_app_type] => utility [patent_app_number] => 11/614726 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4842 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149778.pdf [firstpage_image] =>[orig_patent_app_number] => 11614726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239614 [patent_doc_number] => 07592331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Macrocyclic factor VIIa inhibitors useful as anticoagulants' [patent_app_type] => utility [patent_app_number] => 11/614131 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79152 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592331.pdf [firstpage_image] =>[orig_patent_app_number] => 11614131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759985 [patent_doc_number] => 20080312211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Antibacterial Pyrrolopyridines, Pyrrolopyrimidines and Pyrroloazepines-154' [patent_app_type] => utility [patent_app_number] => 12/158122 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17893 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312211.pdf [firstpage_image] =>[orig_patent_app_number] => 12158122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5035383 [patent_doc_number] => 20070099922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'SULFONYLAMINOVALEROLACTAMS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/611195 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47257 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099922.pdf [firstpage_image] =>[orig_patent_app_number] => 11611195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 289078 [patent_doc_number] => 07547692 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'Rifamycin analogs and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/638756 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16731 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547692.pdf [firstpage_image] =>[orig_patent_app_number] => 11638756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830301 [patent_doc_number] => 07399855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Synthesis of caprolactam from lysine' [patent_app_type] => utility [patent_app_number] => 11/635373 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5715 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399855.pdf [firstpage_image] =>[orig_patent_app_number] => 11635373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281843 [patent_doc_number] => 07553843 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Process for the preparation of purified crystalline CCI-779' [patent_app_type] => utility [patent_app_number] => 11/634774 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7347 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553843.pdf [firstpage_image] =>[orig_patent_app_number] => 11634774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5237384 [patent_doc_number] => 20070129541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate' [patent_app_type] => utility [patent_app_number] => 11/634707 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9494 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20070129541.pdf [firstpage_image] =>[orig_patent_app_number] => 11634707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4798031 [patent_doc_number] => 20080009617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => '3-(4-PIPERIDINYL)-2,3,4,5-TETRAHYDRO-1,3-BENZODIAZEPIN-2(1H)-ON' [patent_app_type] => utility [patent_app_number] => 11/567429 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1854 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009617.pdf [firstpage_image] =>[orig_patent_app_number] => 11567429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808185 [patent_doc_number] => 20080171763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'COMPOUNDS AND METHODS FOR TREATMENT AND PREVENTION OF DISEASES' [patent_app_type] => utility [patent_app_number] => 11/565507 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12531 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171763.pdf [firstpage_image] =>[orig_patent_app_number] => 11565507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496616 [patent_doc_number] => 20090264644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Novel Macrolide Compounds With Antibiotic and Antineoplastic Properties' [patent_app_type] => utility [patent_app_number] => 12/084959 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3024 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264644.pdf [firstpage_image] =>[orig_patent_app_number] => 12084959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4470060 [patent_doc_number] => 07943608 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Diazepinoes' [patent_app_type] => utility [patent_app_number] => 12/158333 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14963 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943608.pdf [firstpage_image] =>[orig_patent_app_number] => 12158333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432350 [patent_doc_number] => 07265123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 11/562047 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44004 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/265/07265123.pdf [firstpage_image] =>[orig_patent_app_number] => 11562047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220317 [patent_doc_number] => 20070161628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Phosphodiesterase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/601778 [patent_app_country] => US [patent_app_date] => 2006-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14178 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161628.pdf [firstpage_image] =>[orig_patent_app_number] => 11601778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 411781 [patent_doc_number] => 07282583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-16 [patent_title] => 'Process for making 5,11-Dihydro-11-ethyl-5-methyl-8{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-di pyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one' [patent_app_type] => utility [patent_app_number] => 11/560536 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5135 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/282/07282583.pdf [firstpage_image] =>[orig_patent_app_number] => 11560536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 588036 [patent_doc_number] => 07439236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Pharmaceutical composition for the treatment of CNS and other disorders' [patent_app_type] => utility [patent_app_number] => 11/559957 [patent_app_country] => US [patent_app_date] => 2006-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19351 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439236.pdf [firstpage_image] =>[orig_patent_app_number] => 11559957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586017 [patent_doc_number] => 20090105219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Spirolactam Tricyclic CGRP Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/085054 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47421 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105219.pdf [firstpage_image] =>[orig_patent_app_number] => 12085054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057646 [patent_doc_number] => 20070060568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => '5HT2c receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/599050 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 27815 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060568.pdf [firstpage_image] =>[orig_patent_app_number] => 11599050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 817255 [patent_doc_number] => 07411063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-12 [patent_title] => 'Process for preparation of maytansinol' [patent_app_type] => utility [patent_app_number] => 11/594156 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 7454 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/411/07411063.pdf [firstpage_image] =>[orig_patent_app_number] => 11594156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005538 [patent_doc_number] => 20070203110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => '17-Allylamino-17-demethoxygeldanamycin polymorphs and formulations' [patent_app_type] => utility [patent_app_number] => 11/595005 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10632 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203110.pdf [firstpage_image] =>[orig_patent_app_number] => 11595005 [rel_patent_id] =>[rel_patent_doc_number] =>)